Social Capital Suvretta III adds Uma Sinha to board; Chamath Palihapitiya leaves audit committee

PROKIDNEY CORP.

Uma Sinha, PhD appointed to board and audit, compensation, and nominating committees effective Sept. 24, 2021.
Chamath Palihapitiya resigned from the audit committee, effective same date; remains CEO.
Sinha granted 30,000 RSUs contingent on initial business combination and shareholder-approved equity plan.
Entered standard letter agreement (lock-up, voting) and indemnity agreement; Sinha determined independent.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Uma Sinha

Director

PROK · PROKIDNEY CORP.

Effective: 2021-09-24
Filed: September 24, 2021, 7:59 PM ET

On September 24, 2021, Uma Sinha PhD was appointed to the board of directors (the “Board”) of Social Capital Suvretta Holdings Corp. III (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Uma Sinha was appointed as Director at PROKIDNEY CORP..

Action: appointed
Role: Director

Exact text from the filing

On September 24, 2021, Uma Sinha PhD was appointed to the board of directors (the “Board”) of Social Capital Suvretta Holdings Corp. III (the “Company”), effective immediately.

View on SEC.gov

PROKIDNEY CORP. filing history →

Source: SEC EDGAR

accession 0001193125-21-282373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.